Estrogen Receptor Beta Agonists (Eviendep) and Polyp Recurrence

Clinical trial NCT01402648 · COMPLETED

Trial details

NCT number: NCT01402648
Sponsor: CM&D Pharma Limited
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Adenocarcinoma of Colon Recurrent

Start date: 2009-10-01
Primary completion: 2011-03-01
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.